GSK and Save the Children initiate healthcare innovation award

Accra, Aug. 
22, GNA – GlaxoSmithKline Pharmaceuticals (GSK) and Save the Children
Foundation have launched their fourth annual Healthcare Innovation Award.

Nominations for the $ 1 million award, which
is to reward innovations in healthcare and also to reduce child deaths in
developing countries, and with the potential to reach even more children is
opened till September 7.

A release issued in Accra on Monday said the
two organisations could nominate innovative healthcare approaches they have
implemented, which resulted in tangible improvements to under-five child
survival, sustainable and have the scope to be scaled-up and replicated.

The Award is one of a number of initiatives
from GSK and Save the Children’s five-year partnership, which combines the two
organisation’s expertise and skills with the aim to help save one million
children’s lives.

According to the release, since 2013, more
than a dozen inventive approaches – from a breast milk pasteurisation device to
an affordable diarrhea treatment kit – have been recognised through the Award.

General Manager for GSK in Ghana, Mark
Pfister, said: “When it comes to reaching the most vulnerable Ghanaian children
with quality healthcare, no single organisation has all the answers. So we’re
always searching for new and different ideas, wherever they might be.”

“Our Award recognises that some of the best
solutions to development challenges come from people living with them. Tough
conditions can stimulate innovation, generating solutions that are relevant and
adaptable. If these bright ideas can be shared across countries and continents,
the impact could be profound,” he noted.

Outlining the focus of this year’s Award,
the Director of Programme, Policy and Quality at Save the Children, Ali Forder
said progress has been made in the campaign to save more children from child
death but there are more children they seek to reach out to.

“Extraordinary progress has been made in
recent years to reduce the number of children dying before their fifth
birthday.

“Despite this progress, more than five
million children still die each year and millions of children are being left
behind because of their gender, poverty, or ethnic identity.

“Because they live in remote areas or urban
slums; or because they are caught up in conflicts. We want to seek out and
recognise ways in which these children can be reached,” he stated.

According to the release, a judging panel,
made up of experts from the fields of public health, science and academia,
would award all or part of the funds to one or more of the best healthcare
innovations.

Interested participants should log on for
further details on the judging process and criteria online at
www.healthcareinnovationaward.org

Entries close on 7 September 2016 at 11:59pm
(GMT), with winners being expected to be    
announced in December.

GSK, one of the world’s leading
research-based pharmaceutical and healthcare companies – is committed to
improving the quality of human life by enabling people to do more, feel better
and live longer.  For further information
please visit www.gsk.com.

Save the Children – an international
non-governmental organisation that believes every child deserves a future. In
the UK and around the world, we give children a healthy start in life, the
opportunity to learn and protection from harm. We do whatever it takes for
children – every day and in times of crisis – transforming their lives and the
future we share. For further information please visit
www.savethechildren.org.uk.

Nominations must:

1)  
Be from a country classified as ‘low’, ‘lower-middle’, or ‘upper-middle’
income by the World Bank (http://data.worldbank.org/country). Countries
classified as ‘high income’ by the World Bank or that are in the European Union
are not eligible (http://europa.eu/about-eu/countries/index_en.htm).

2)  
Describe an innovative approach or process applied to under-5 child
survival that can demonstrate impact within an eligible country.

About the Healthcare Innovation Award

The Healthcare Innovation Award was
announced following the launch of GSK and Save the Children’s innovative
partnership in May 2013, which is tackling the ambitious goal of helping save
the lives of one million children in some of the world’s most vulnerable
communities.

The GSK and Save the Children Healthcare
Innovation Award aims to discover and encourage replication of the best and
most innovative examples of healthcare to have the biggest impact for
vulnerable children.

In 2013, a device that eases the breathing
of babies in respiratory distress which was awarded the highest share of the
Healthcare Innovation Award prize fund.

It was developed by the College of
Medicine/Friends of Sick Children, Malawi and Rice 360° Institute for Global
Health Technologies.

Commenting on the impact of the Award,
Professor Elizabeth Molyneux, Professor of Pediatrics at the College of
Medicine and Queen Elizabeth Central Teaching Hospital, Blantyre, Malawi, said:
“It was exciting to win the Award, which has allowed us to provide technology
and training in teaching hospitals in Tanzania, Zambia and South Africa.”

Funding from GSK and others shows confidence
in what we are offering and gives us a chance to share with people who will
benefit from it.”

GNA

About ghanamma

Leave a Reply